Cover Image
Market Research Report

Molecular Diagnostics Market Size, Share & Trends Analysis Report By Technology, By Test Location, By Product (Instruments, Reagents), By Application (Oncology, Infectious Diseases), And Segment Forecasts, 2019 - 2026

Published by Grand View Research, Inc. Product code 355233
Published Content info 185 Pages
Delivery time: 2-3 business days
Price
Back to Top
Molecular Diagnostics Market Size, Share & Trends Analysis Report By Technology, By Test Location, By Product (Instruments, Reagents), By Application (Oncology, Infectious Diseases), And Segment Forecasts, 2019 - 2026
Published: April 9, 2019 Content info: 185 Pages
Description

The global molecular diagnostics market size is expected to reach USD 19.8 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 9.1% over the forecast period. Increasing prevalence of infectious diseases, such as human papillomavirus and influenza, is expected to be the primary force driving the market.

Instruments such as PCR and next generation sequencing platforms are widely preferred by central laboratories and diagnostic institutes due to rapid nature of these tests in delivering quick and reliable results and high volume of diagnostic procedures in this segment. Associated advantages including user-friendly nature of these tests and quick healthcare delivery are estimated to propel the point-of-care segment growth.

In underdeveloped regions of Africa and Nigeria, other infections such as HIV and tuberculosis are increasing at a high rate since the last few years. This is estimated to increase demand for early and accurate diagnostic techniques to curb their surge.

Molecular testing tools provide clinicians with better alternatives to detect countless infectious bacteria, virus, and pathogens in a short time while delivering highly accurate results. Initiatives led by organizations such as the WHO to conduct diagnostic programs in regions with high risk areas are estimated to be a high rendering driver.

Prenatal genetic testing, performed for the purpose of early detection of abnormalities that develop in the fetuses, is also expected to widen the client base for the molecular diagnostics market. Moreover, high adoption of unhealthy lifestyles resulting in a large patient count afflicted with chronic diseases such as diabetes and cardiovascular disorders is projected to positively impact the growth.

Rising healthcare spending, increasing awareness among patients, and expansion of R&D activities related to drug discovery and development are expected to drive the market in North America and Europe. Rising demand for improved diagnostic technologies employed for the prevention of epidemics, unaddressed clinical needs, and recent activities by key players targeting expansion in this region are the major factors supporting the market growth in Asia Pacific.

Key players are advancing strategic collaborations with major technology-based companies and diagnostic centers and tapping developing regions in an attempt to increase their market share and attain stability.

Further key findings from the study suggest:

On the basis of product, reagents were the largest revenue generating segment in 2018 owing to their elevated usage rates. Reagents are key products used in academic and research institutes to perform various molecular biology protocols, further contributing towards the growth of this segment

Based on test location, central laboratories led the market with the largest market share in 2018 owing to their established base in the remote and developing regions. The point-of-care segment is expected to witness the fastest growth over the forecast period

On the basis of application, infectious diseases dominated the overall molecular diagnostics market in 2018. The oncology application segment is expected to exhibit a CAGR of around 11.8% over the forecast period due to rising awareness among people as well as healthcare professionals pertaining to cancer diagnosis

Based on technology, the polymerase chain reaction (PCR) dominated the market in terms of revenue in 2018, attributed to growing applications of multiplex PCR over the conventional PCR procedure and introduction of easy-to-use PCR handling kits

North America emerged as the largest regional segment in 2018, followed by Europe, primarily driven by well-established healthcare infrastructure. Asia Pacific is expected witness the fastest growth over the forecast period

Some of the major players are Novartis AG (Grifols); Siemens Healthcare GmbH; Bio-Rad Laboratories, Inc.; Alere, Inc.; Danaher Corporation; BioMerieux SA; Sysmex Corporation; Becton; Dickinson and Company; Johnson & Johnson Services, Inc.; Bio-Rad Laboratories, Inc.; Bayer AG, Qiagen; Hologic, Inc. (Gen Probe); Cepheid; F. Hoffmann-La Roche Ltd; and Dako.

Table of Contents
Product Code: 978-1-68038-086-6

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources & Third party perspectives
    • 1.3.4. Primary research
  • 1.4. Information Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Molecular Diagnostics Market Variables, Trends & Scope

  • 3.1. Molecular Diagnostics Market Lineage outlook
    • 3.1.1. IVD market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Regulatory Framework
    • 3.3.1. Reimbursement framework
    • 3.3.2. Standards & compliances
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increase in geriatric population
      • 3.4.1.2. Introduction of technologically advanced products
      • 3.4.1.3. Increase in demand for point-of-care facilities
      • 3.4.1.4. Growing prevalence of target diseases
      • 3.4.1.5. Increasing external funding for R&D
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Presence of ambiguous regulatory framework
      • 3.4.2.2 High prices of molecular diagnostics tests
  • 3.5. Molecular Diagnostics Market Analysis Tools
    • 3.5.1. Industry analysis - Porter's
      • 3.5.1.1. Supplier power (Moderate due to requirement of high-quality raw materials)
      • 3.5.1.2. Buyer power (Low due to limited number of established providers)
      • 3.5.1.3. Substitution threat (Moderate due to high prices of molecular tests)
      • 3.5.1.4. New entrants' threat (Moderate due to manufacturing capital is high)
      • 3.5.1.5. Competitive rivalry (High due to presence of many key players)
    • 3.5.2. PESTEL analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Environmental landscape
      • 3.5.2.3. Social landscape
      • 3.5.2.4. Technology landscape
      • 3.5.2.5. Legal landscape
    • 3.5.3. Major deals & strategic alliances analysis
      • 3.5.3.1. Joint ventures
      • 3.5.3.2. Mergers & acquisitions
      • 3.5.3.3. Licensing & partnership
      • 3.5.3.4. Technology collaborations
      • 3.5.3.5. Strategic divestments

Chapter 4. Molecular Diagnostics Market - Competitive Analysis

  • 4.1. Recent Developments & Impact Analysis, by Key Market Participants
  • 4.2. Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
  • 4.3. Vendor Landscape
    • 4.3.1. List of key distributors and channel partners
    • 4.3.2. Key company market share analysis, 2018
  • 4.4. Public Companies
    • 4.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 4.4.2. Company market share
    • 4.4.3. Competitive dashboard analysis
    • 4.4.4. Market differentiators
    • 4.4.5. Synergy analysis: Major deals & strategic alliances
  • 4.5. Private Companies
    • 4.5.1. List of key emerging companies
    • 4.5.2. Regional network map
    • 4.5.3. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)

Chapter 5. Molecular Diagnostics Market: Product Estimates & Trend Analysis

  • 5.1. Definitions & Scope
  • 5.2. Product Market Share Analysis, 2018 & 2026
  • 5.3. Molecular Diagnostics Market, by Product, 2014 to 2026
  • 5.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
    • 5.4.1. Instruments
      • 5.4.1.1 Instrument market, 2014 - 2026 (USD Million)
    • 5.4.2. Reagents
      • 5.4.2.1 Reagents market, 2014 - 2026 (USD Million)
    • 5.4.3. Others
      • 5.4.3.1 Others market, 2014 - 2026 (USD Million)

Chapter 6. Molecular Diagnostics Market: Test Location Estimates & Trend Analysis

  • 6.1. Definitions & Scope
  • 6.2. Test Location Market Share Analysis, 2018 & 2026
  • 6.3. Molecular Diagnostics Market, by Test Location, 2014 to 2026
  • 6.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
    • 6.4.1. Point of care
      • 6.4.1.1 Point of care market, 2014 - 2026 (USD Million)
    • 6.4.2. Self-test or OTC
      • 6.4.2.1 Self-test or OTC market, 2014 - 2026 (USD Million)
    • 6.4.3. Central laboratories
      • 6.4.3.1 Central laboratories market, 2014 - 2026 (USD Million)

Chapter 7. Molecular Diagnostics Market: Technology Estimates & Trend Analysis

  • 7.1. Definitions & Scope
  • 7.2. Technology Market Share Analysis, 2018 & 2026
  • 7.3. Molecular Diagnostics Market, by Technology, 2014 to 2026
  • 7.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
    • 7.4.1. PCR
      • 7.4.1.1 PCR market, 2014 - 2026 (USD Million)
      • 7.4.1.2 Multiplex PCR
      • 7.4.1.2.1 Multiplex PCR market, 2014 - 2026 (USD Million)
      • 7.4.1.3 Others
      • 7.4.1.3.1 Others market, 2014 - 2026 (USD Million)
    • 7.4.2. ISH
      • 7.4.2.1 ISH market, 2014 - 2026 (USD Million)
    • 7.4.3. INAAT
      • 7.4.3.1 INAAT market, 2014 - 2026 (USD Million)
    • 7.4.4. Chips and microarrays
      • 7.4.4.1 Chips and microarrays market, 2014 - 2026 (USD Million)
    • 7.4.5. Mass spectrometry
      • 7.4.5.1 Mass spectrometry market, 2014 - 2026 (USD Million)
    • 7.4.6. Sequencing
      • 7.4.6.1 Sequencing market, 2014 - 2026 (USD Million)
    • 7.4.7. TMA
      • 7.4.7.1 TMA market, 2014 - 2026 (USD Million)
    • 7.4.8. Others
      • 7.4.8.1 Others market, 2014 - 2026 (USD Million)
  • 7.5. Technology Markets, by Product, 2014 to 2026:
    • 7.5.1. PCR
      • 7.5.1.1 Instruments
      • 7.5.1.1.1 Instrument market, 2014 - 2026 (USD Million)
      • 7.5.1.2 Reagents
      • 7.5.1.2.1 Reagents market, 2014 - 2026 (USD Million)
      • 7.5.1.3 Others
      • 7.5.1.3.1 Others market, 2014 - 2026 (USD Million)
    • 7.5.2. ISH
      • 7.5.2.1 Instruments
      • 7.5.2.1.1 Instrument market, 2014 - 2026 (USD Million)
      • 7.5.2.2. Reagents
      • 7.5.2.2.1 Reagents market, 2014 - 2026 (USD Million)
      • 7.5.2.3 Others
      • 7.5.2.3.1 Others market, 2014 - 2026 (USD Million)
    • 7.5.3. INAAT
      • 7.5.3.1 Instruments
      • 7.5.3.1.1 Instrument market, 2014 - 2026 (USD Million)
      • 7.5.3.2. Reagents
      • 7.5.3.2.1 Reagents market, 2014 - 2026 (USD Million)
      • 7.5.3.3 Others
      • 7.5.3.3.1 Others market, 2014 - 2026 (USD Million)
    • 7.5.4. Chips and microarrays
      • 7.5.4.1 Instruments
      • 7.5.4.1.1 Instrument market, 2014 - 2026 (USD Million)
      • 7.5.4.2. Reagents
      • 7.5.4.2.1 Reagents market, 2014 - 2026 (USD Million)
      • 7.5.4.3 Others
      • 7.5.4.3.1 Others market, 2014 - 2026 (USD Million)
    • 7.5.5. Mass spectrometry
      • 7.5.5.1 Instruments
      • 7.5.5.1.1 Instrument market, 2014 - 2026 (USD Million)
      • 7.5.5.2. Reagents
      • 7.5.5.2.1 Reagents market, 2014 - 2026 (USD Million)
      • 7.5.5.3 Others
      • 7.5.5.3.1 Others market, 2014 - 2026 (USD Million)
    • 7.5.6. Sequencing
      • 7.5.6.1 Instruments
      • 7.5.6.1.1 Instrument market, 2014 - 2026 (USD Million)
      • 7.5.6.2. Reagents
      • 7.5.6.2.1 Reagents market, 2014 - 2026 (USD Million)
      • 7.5.6.3 Others
      • 7.5.6.3.1 Others market, 2014 - 2026 (USD Million)
    • 7.5.7. TMA
      • 7.5.7.1 Instruments
      • 7.5.7.1.1 Instrument market, 2014 - 2026 (USD Million)
      • 7.5.7.2. Reagents
      • 7.5.7.2.1 Reagents market, 2014 - 2026 (USD Million)
      • 7.5.7.3 Others
      • 7.5.7.3.1 Others market, 2014 - 2026 (USD Million)
    • 7.5.8. Others
      • 7.5.8.1 Instruments
      • 7.5.8.1.1 Instrument market, 2014 - 2026 (USD Million)
      • 7.5.8.2. Reagents
      • 7.5.8.2.1 Reagents market, 2014 - 2026 (USD Million)
      • 7.5.8.3 Others
      • 7.5.8.3.1 Others market, 2014 - 2026 (USD Million)

Chapter 8. Molecular Diagnostics Market: Application Estimates & Trend Analysis

  • 8.1. Definitions & Scope
  • 8.2. Application Market Share Analysis, 2018 & 2026
  • 8.3. Molecular Diagnostics Market, by Application, 2014 to 2026
  • 8.4. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
    • 8.4.1. Oncology
      • 8.4.1.1 Oncology market, 2014 - 2026 (USD Million)
      • 8.4.1.2 Breast cancer
      • 8.4.1.2.1 Breast cancer market, 2014 - 2026 (USD Million)
      • 8.4.1.3 Prostate cancer
      • 8.4.1.3.1 Prostate cancer market, 2014 - 2026 (USD Million)
      • 8.4.1.4 Colorectal cancer
      • 8.4.1.4.1 Colorectal cancer market, 2014 - 2026 (USD Million)
      • 8.4.1.5 Cervical cancer
      • 8.4.1.5.1 Cervical cancer market, 2014 - 2026 (USD Million)
      • 8.4.1.6 Kidney cancer
      • 8.4.1.6.1 Kidney cancer market, 2014 - 2026 (USD Million)
      • 8.4.1.7 Liver cancer
      • 8.4.1.7.1 Liver cancer market, 2014 - 2026 (USD Million)
      • 8.4.1.8 Blood cancer
      • 8.4.1.8.1 Blood cancer market, 2014 - 2026 (USD Million)
      • 8.4.1.9 Lung cancer
      • 8.4.1.9.1 Lung cancer market, 2014 - 2026 (USD Million)
      • 8.4.1.10 Others
      • 8.4.1.10.1 Others market, 2014 - 2026 (USD Million)
    • 8.4.2. Pharmacogenomics
      • 8.4.2.1 Pharmacogenomics market, 2014 - 2026 (USD Million)
    • 8.4.3. Infectious disease
      • 8.4.3.1 Infectious disease market, 2014 - 2026 (USD Million)
      • 8.4.3.2 MRSA
      • 8.4.3.2.1 MRSA market, 2014 - 2026 (USD Million)
      • 8.4.3.3 Clostridium difficile
      • 8.4.3.3.1 Clostridium difficile market, 2014 - 2026 (USD Million)
      • 8.4.3.4 Vancomycin-resistant enterococci
      • 8.4.3.4.1 Vancomycin-resistant enterococci market, 2014 - 2026 (USD Million)
      • 8.4.3.5 Carbapenem-resistant bacteria
      • 8.4.3.5.1 Carbapenem-resistant bacteria, 2014 - 2026 (USD Million)
      • 8.4.3.6 Flu
      • 8.4.3.6.1 Flu market, 2014 - 2026 (USD Million)
      • 8.4.3.7 Respiratory syncytial virus (RSV)
      • 8.4.3.7.1 Respiratory syncytial virus (RSV) market, 2014 - 2026 (USD Million)
      • 8.4.3.8 Candida
      • 8.4.3.8.1 Candida market, 2014 - 2026 (USD Million)
      • 8.4.3.9 Tuberculosis and drug-resistant TBA
      • 8.4.3.9.1 Tuberculosis and drug-resistant TBA market, 2014 - 2026 (USD Million)
      • 8.4.3.10 Meningitis
      • 8.4.3.10.1 Meningitis market, 2014 - 2026 (USD Million)
      • 8.4.3.11 Gastrointestinal panel testing
      • 8.4.3.11.1 Gastrointestinal panel testing market, 2014 - 2026 (USD Million)
      • 8.4.3.12 Chlamydia
      • 8.4.3.12.1 Chlamydia market, 2014 - 2026 (USD Million)
      • 8.4.3.13 Gonorrhea
      • 8.4.3.13.1 Gonorrhea market, 2014 - 2026 (USD Million)
      • 8.4.3.14 HIV
      • 8.4.3.14.1 HIV market, 2014 - 2026 (USD Million)
      • 8.4.3.15 Hepatitis C
      • 8.4.3.15.1 Hepatitis C market, 2014 - 2026 (USD Million)
      • 8.4.3.16 Hepatitis B
      • 8.4.3.16.1 Hepatitis B market, 2014 - 2026 (USD Million)
      • 8.4.3.17 Other
      • 8.4.3.17.1 Other market, 2014 - 2026 (USD Million)
    • 8.4.4. Genetic testing
      • 8.4.4.1 Genetic testing market, 2014 - 2026 (USD Million)
      • 8.4.4.2 Newborn screening
      • 8.4.4.2.1 Newborn screening market, 2014 - 2026 (USD Million)
      • 8.4.4.3 Predictive and presymptomatic testing
      • 8.4.4.3.1 Predictive and presymptomatic testing market, 2014 - 2026 (USD Million)
      • 8.4.4.4 Others
      • 8.4.4.4.1 Others market, 2014 - 2026 (USD Million)
    • 8.4.5. Neurological disease
      • 8.4.5.1 Neurological disease market, 2014 - 2026 (USD Million)
    • 8.4.6. Cardiovascular disease
      • 8.4.6.1 Cardiovascular disease market, 2014 - 2026 (USD Million)
    • 8.4.7. Microbiology
      • 8.4.7.1 Microbiology market, 2014 - 2026 (USD Million)
    • 8.4.8. Others
      • 8.4.8.1 Others market, 2014 - 2026 (USD Million)

Chapter 9 Molecular Diagnostics Market: Regional Estimates & Trend Analysis, by Product, Test Location, Technology, & Application

  • 9.1 Molecular Diagnostics Market: Regional Movement Analysis, 2018 & 2026
  • 9.2 Molecular Diagnostics Market: Leading Players, 2018:
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East & Africa
  • 9.4 North America
    • 9.4.1 North America market, 2014 - 2026 (USD Million)
    • 9.4.2 U.S.
      • 9.4.2.1 U.S. market, 2014 - 2026 (USD Million)
    • 9.4.3 Canada
      • 9.4.3.1 Canada market, 2014 - 2026 (USD Million)
  • 9.5. Europe
    • 9.5.1 Europe market, 2014 - 2026 (USD Million)
    • 9.5.2 U.K.
      • 9.5.2.1 U.K. market, 2014 - 2026 (USD Million)
    • 9.5.3 Germany
      • 9.5.3.1 Germany market, 2014 - 2026 (USD Million)
    • 9.5.4 France
      • 9.5.4.1 France market, 2014 - 2026 (USD Million)
    • 9.5.5 Spain
      • 9.5.5.1 Spain market, 2014 - 2026 (USD Million)
    • 9.5.6 Italy
      • 9.5.6.1 Italy market, 2014 - 2026 (USD Million)
    • 9.5.7 Belgium
      • 9.5.7.1 Belgium market, 2014 - 2026 (USD Million)
    • 9.5.8 Switzerland
      • 9.5.8.1 Switzerland market, 2014 - 2026 (USD Million)
    • 9.5.9 Netherlands
      • 9.5.9.1 Netherlands market, 2014 - 2026 (USD Million)
    • 9.5.10 Poland
      • 9.5.10.1 Poland market, 2014 - 2026 (USD Million)
    • 9.5.11 Austria
      • 9.5.11.1 Austria market, 2014 - 2026 (USD Million)
    • 9.5.12 Greece
      • 9.5.12.1 Greece market, 2014 - 2026 (USD Million)
    • 9.5.13 Sweden
      • 9.5.13.1 Sweden market, 2014 - 2026 (USD Million)
    • 9.5.14 Turkey
      • 9.5.14.1 Turkey market, 2014 - 2026 (USD Million)
    • 9.5.15 Finland
      • 9.5.15.1 Finland market, 2014 - 2026 (USD Million)
  • 9.6 Asia Pacific
    • 9.6.1 Asia Pacific market, 2014 - 2026 (USD Million)
    • 9.6.2 Japan
      • 9.6.2.1 Japan market, 2014 - 2026 (USD Million)
    • 9.6.3 China
      • 9.6.3.1 China market, 2014 - 2026 (USD Million)
    • 9.6.4 India
      • 9.6.4.1 India market, 2014 - 2026 (USD Million)
    • 9.6.5 Australia
      • 9.6.5.1 Australia market, 2014 - 2026 (USD Million)
    • 9.6.6 New Zealand
      • 9.6.6.1 New Zealand market, 2014 - 2026 (USD Million)
    • 9.6.7 Sri Lanka
      • 9.6.7.1 Sri Lanka market, 2014 - 2026 (USD Million)
    • 9.6.8 Malaysia
      • 9.6.8.1 Malaysia market, 2014 - 2026 (USD Million)
    • 9.6.9 Thailand
      • 9.6.9.1 Thailand market, 2014 - 2026 (USD Million)
    • 9.6.10 Vietnam
      • 9.6.10.1 Vietnam market, 2014 - 2026 (USD Million)
    • 9.6.11 Singapore
      • 9.6.11.1 Singapore market, 2014 - 2026 (USD Million)
  • 9.7 Latin America
    • 9.7.1 Latin America market, 2014 - 2026 (USD Million)
    • 9.7.2 Brazil
      • 9.7.2.1 Brazil market, 2014 - 2026 (USD Million)
    • 9.7.3 Mexico
      • 9.7.3.1 Mexico market, 2014 - 2026 (USD Million)
    • 9.7.4 Colombia
      • 9.7.4.1 Colombia market, 2014 - 2026 (USD Million)
    • 9.7.5 Chile
      • 9.7.5.1 Chile market, 2014 - 2026 (USD Million)
    • 9.7.6 Peru
      • 9.7.6.1 Peru market, 2014 - 2026 (USD Million)
    • 9.7.7 Argentina
      • 9.7.7.1 Argentina market, 2014 - 2026 (USD Million)
  • 9.8 MEA
    • 9.8.1 MEA market, 2014 - 2026 (USD Million)
    • 9.8.2 South Africa
      • 9.8.2.1 South Africa market, 2014 - 2026 (USD Million)
    • 9.8.3 Saudi Arabia
      • 9.8.3.1 Saudi Arabia market, 2014 - 2026 (USD Million)
    • 9.8.4 Jordan
      • 9.8.4.1 Jordan Arabia market, 2014 - 2026 (USD Million)
    • 9.8.5 UAE
      • 9.8.5.1 UAE Arabia market, 2014 - 2026 (USD Million)
    • 9.8.6 Qatar
      • 9.8.6.1 Qatar Arabia market, 2014 - 2026 (USD Million)
    • 9.8.7 Nigeria
      • 9.8.7.1 Nigeria Arabia market, 2014 - 2026 (USD Million)
    • 9.8.8 Egypt
      • 9.8.8.1 Egypt Arabia market, 2014 - 2026 (USD Million)

Chapter 10 Competitive Landscape

  • 10.1 Strategy Framework
  • 10.2 Heat Map Analysis of Private Companies
    • 10.2.1 Company size
    • 10.2.2 Distribution network
    • 10.2.3 Product portfolio
    • 10.2.4 Segment coverage
    • 10.2.5 Geographic presence
    • 10.2.6 Collaborations
    • 10.2.7 Conclusion
  • 10.3 Abbott
    • 10.3.1 Company overview
    • 10.3.2 Financial performance
    • 10.3.3 Product benchmarking
    • 10.3.4 Strategic initiatives
  • 10.4 Becton, Dickinson and Company
    • 10.4.1 Company overview
    • 10.4.2 Financial performance
    • 10.4.3 Product benchmarking
    • 10.4.4 Strategic initiatives
  • 10.5 bioMerieux SA
    • 10.5.1 Company overview
    • 10.5.2 Financial performance
    • 10.5.3 Product benchmarking
    • 10.5.4 Strategic initiatives
  • 10.6 Bio-Rad Laboratories, Inc.
    • 10.6.1 Company overview
    • 10.6.2 Financial performance
    • 10.6.3 Product benchmarking
    • 10.6.4 Strategic initiatives
  • 10.7 Dako
    • 10.7.1 Company overview
    • 10.7.2 Financial performance
    • 10.7.3 Product benchmarking
    • 10.7.4 Strategic initiatives
  • 10.8 Danaher Corporation
    • 10.8.1 Company overview
    • 10.8.2 Financial performance
    • 10.8.3 Product benchmarking
    • 10.8.4 Strategic initiatives
  • 10.9 Hologic, Inc. (Gen Probe)
    • 10.9.1 Company overview
    • 10.9.2 Financial performance
    • 10.9.3 Product benchmarking
    • 10.9.4 Strategic initiatives
  • 10.10 Illumina, Inc.
    • 10.10.1 Company overview
    • 10.10.2 Product benchmarking
    • 10.10.3 Strategic initiatives
  • 10.11 Johnson & Johnson Services, Inc
    • 10.11.1 Company Overview
    • 10.11.2 Financial performance
    • 10.11.3 Product benchmarking
    • 10.11.4 Strategic initiatives
  • 10.12 Novartis (Grifols)
    • 10.12.1 Company overview
    • 10.12.2 Financial performance
    • 10.12.3 Product benchmarking
    • 10.12.4 Strategic initiatives
  • 10.13 Qiagen
    • 10.13.1 Company overview
    • 10.13.2 Financial overview
    • 10.13.3 Product benchmarking
    • 10.13.4 Strategic initiatives
  • 10.14 Roche Diagnostics
    • 10.14.1 Company overview
    • 10.14.2 Financial overview
    • 10.14.3 Product benchmarking
    • 10.14.4 Strategic initiatives
  • 10.15 Siemens Healthcare Private Limited
    • 10.15.1 Company overview
    • 10.15.2 Financial performance
    • 10.15.3 Product benchmarking
    • 10.15.4 Strategic initiatives
  • 10.16 Sysmex Corporation
    • 10.16.1 Company overview
    • 10.16.2 Financial performance
    • 10.16.3 Products benchmarking
    • 10.16.4 Strategic initiatives

List of Tables

  • TABLE 1 Country share estimation
  • TABLE 2 North America molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 3 North America molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 4 North America molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 5 North America PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 6 North America PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 7 North America ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 8 North America INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 9 North America chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 10 North America mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 11 North America sequencing market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 12 North America TMA market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 13 North America others technology market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 14 North America molecular diagnostics market estimates and forecasts, by application, 2014 - 2026 (USD Million)
  • TABLE 15 North America molecular diagnostics market estimates and forecasts, by oncology, 2014 - 2026 (USD Million)
  • TABLE 16 North America molecular diagnostics market estimates and forecasts, by infectious diseases, 2014 - 2026 (USD Million)
  • TABLE 17 North America molecular diagnostics market estimates and forecasts, by genetic testing, 2014 - 2026 (USD Million)
  • TABLE 18 U.S. molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 19 U.S. molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 20 U.S. molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 21 U.S. PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 22 U.S. PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 23 U.S. ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 24 U.S. INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 25 U.S. chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 26 U.S. mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 27 U.S. sequencing market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 28 U.S. TMA market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 29 U.S. others technology market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 30 U.S. molecular diagnostics market estimates and forecasts, by application, 2014 - 2026 (USD Million)
  • TABLE 31 U.S. molecular diagnostics market estimates and forecasts, by oncology, 2014 - 2026 (USD Million)
  • TABLE 32 U.S. molecular diagnostics market estimates and forecasts, by infectious diseases, 2014 - 2026 (USD Million)
  • TABLE 33 U.S. molecular diagnostics market estimates and forecasts, by genetic testing, 2014 - 2026 (USD Million)
  • TABLE 34 Canada molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 35 Canada molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 36 Canada molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 37 Canada PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 38 Canada PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 39 Canada ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 40 Canada INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 41 Canada chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 42 Canada mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 43 Canada sequencing market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 44 Canada TMA market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 45 Canada others technology market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 46 Canada molecular diagnostics market estimates and forecasts, by application, 2014 - 2026 (USD Million)
  • TABLE 47 Canada molecular diagnostics market estimates and forecasts, by oncology, 2014 - 2026 (USD Million)
  • TABLE 48 Canada molecular diagnostics market estimates and forecasts, by infectious diseases, 2014 - 2026 (USD Million)
  • TABLE 49 Canada molecular diagnostics market estimates and forecasts, by genetic testing, 2014 - 2026 (USD Million)
  • TABLE 50 Europe molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 51 Europe molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 52 Europe molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 53 Europe PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 54 Europe PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 55 Europe ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 56 Europe INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 57 Europe chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 58 Europe mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 59 Europe sequencing market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 60 Europe TMA market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 61 Europe others technology market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 62 Europe molecular diagnostics market estimates and forecasts, by application, 2014 - 2026 (USD Million)
  • TABLE 63 Europe molecular diagnostics market estimates and forecasts, by oncology, 2014 - 2026 (USD Million)
  • TABLE 64 Europe molecular diagnostics market estimates and forecasts, by infectious diseases, 2014 - 2026 (USD Million)
  • TABLE 65 Europe molecular diagnostics market estimates and forecasts, by genetic testing, 2014 - 2026 (USD Million)
  • TABLE 66 U.K. molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 67 U.K. molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 68 U.K. molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 69 U.K. PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 70 U.K. PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 71 U.K. ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 72 U.K. INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 73 U.K. chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 74 U.K. mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 75 U.K. sequencing market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 76 U.K. TMA market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 77 U.K. others technology market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 78 U.K. molecular diagnostics market estimates and forecasts, by application, 2014 - 2026 (USD Million)
  • TABLE 79 U.K. molecular diagnostics market estimates and forecasts, by oncology, 2014 - 2026 (USD Million)
  • TABLE 80 U.K. molecular diagnostics market estimates and forecasts, by infectious diseases, 2014 - 2026 (USD Million)
  • TABLE 81 U.K. molecular diagnostics market estimates and forecasts, by genetic testing, 2014 - 2026 (USD Million)
  • TABLE 82 Germany molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 83 Germany molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 84 Germany molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 85 Germany PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 86 Germany PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 87 Germany ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 88 Germany INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 89 Germany chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 90 Germany mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 91 Germany sequencing market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 92 Germany TMA market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 93 Germany others technology market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 94 Germany molecular diagnostics market estimates and forecasts, by application, 2014 - 2026 (USD Million)
  • TABLE 95 Germany molecular diagnostics market estimates and forecasts, by oncology, 2014 - 2026 (USD Million)
  • TABLE 96 Germany molecular diagnostics market estimates and forecasts, by infectious diseases, 2014 - 2026 (USD Million)
  • TABLE 97 Germany molecular diagnostics market estimates and forecasts, by genetic testing, 2014 - 2026 (USD Million)
  • TABLE 98 France molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 99 France molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 100 France molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 101 France PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 102 France PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 103 France ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 104 France INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 105 France chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 106 France mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 107 France sequencing market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 108 France TMA market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 109 France others technology market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 110 France molecular diagnostics market estimates and forecasts, by application, 2014 - 2026 (USD Million)
  • TABLE 111 France molecular diagnostics market estimates and forecasts, by oncology, 2014 - 2026 (USD Million)
  • TABLE 112 France molecular diagnostics market estimates and forecasts, by infectious diseases, 2014 - 2026 (USD Million)
  • TABLE 113 France molecular diagnostics market estimates and forecasts, by genetic testing, 2014 - 2026 (USD Million)
  • TABLE 114 Spain molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 115 Spain molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 116 Spain molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 117 Spain PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 118 Spain PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 119 Spain ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 120 Spain INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 121 Spain chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 122 Spain mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 123 Spain sequencing market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 124 Spain TMA market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 125 Spain others technology market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 126 Spain molecular diagnostics market estimates and forecasts, by application, 2014 - 2026 (USD Million)
  • TABLE 127 Spain molecular diagnostics market estimates and forecasts, by oncology, 2014 - 2026 (USD Million)
  • TABLE 128 Spain molecular diagnostics market estimates and forecasts, by infectious diseases, 2014 - 2026 (USD Million)
  • TABLE 129 Spain molecular diagnostics market estimates and forecasts, by genetic testing, 2014 - 2026 (USD Million)
  • TABLE 130 Italy molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 131 Italy molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 132 Italy molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 133 Italy PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 134 Italy PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 135 Italy ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 136 Italy INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 137 Italy chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 138 Italy mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 139 Italy sequencing market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 140 Italy TMA market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 141 Italy others technology market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 142 Italy molecular diagnostics market estimates and forecasts, by application, 2014 - 2026 (USD Million)
  • TABLE 143 Italy molecular diagnostics market estimates and forecasts, by oncology, 2014 - 2026 (USD Million)
  • TABLE 144 Italy molecular diagnostics market estimates and forecasts, by infectious diseases, 2014 - 2026 (USD Million)
  • TABLE 145 Italy molecular diagnostics market estimates and forecasts, by genetic testing, 2014 - 2026 (USD Million)
  • TABLE 146 Belgium molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 147 Belgium molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 148 Belgium molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 149 Belgium PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 150 Belgium PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 151 Belgium ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 152 Belgium INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 153 Belgium chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 154 Belgium mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 155 Belgium sequencing market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 156 Belgium TMA market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 157 Belgium others technology market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 158 Belgium molecular diagnostics market estimates and forecasts, by application, 2014 - 2026 (USD Million)
  • TABLE 159 Belgium molecular diagnostics market estimates and forecasts, by oncology, 2014 - 2026 (USD Million)
  • TABLE 160 Belgium molecular diagnostics market estimates and forecasts, by infectious diseases, 2014 - 2026 (USD Million)
  • TABLE 161 Belgium molecular diagnostics market estimates and forecasts, by genetic testing, 2014 - 2026 (USD Million)
  • TABLE 162 Switzerland molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 163 Switzerland molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 164 Switzerland molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 165 Switzerland PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 166 Switzerland PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 167 Switzerland ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 168 Switerland INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 169 Switzerland chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 170 Switzerland mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 171 Switzerland sequencing market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 172 Switzerland TMA market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 173 Switzerland others technology market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 174 Switzerland molecular diagnostics market estimates and forecasts, by application, 2014 - 2026 (USD Million)
  • TABLE 175 Switzerland molecular diagnostics market estimates and forecasts, by oncology, 2014 - 2026 (USD Million)
  • TABLE 176 Switzerland molecular diagnostics market estimates and forecasts, by infectious diseases, 2014 - 2026 (USD Million)
  • TABLE 177 Switzerland molecular diagnostics market estimates and forecasts, by genetic testing, 2014 - 2026 (USD Million)
  • TABLE 178 Netherlands molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 179 Netherlands molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 180 Netherlands molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 181 Netherlands PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 182 Netherlands PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 183 Netherlands ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 184 Netherlands INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 185 Netherlands chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 186 Netherlands mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 187 Netherlands sequencing market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 188 Netherlands TMA market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 189 Netherlands others technology market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 190 Netherlands molecular diagnostics market estimates and forecasts, by application, 2014 - 2026 (USD Million)
  • TABLE 191 Netherlands molecular diagnostics market estimates and forecasts, by oncology, 2014 - 2026 (USD Million)
  • TABLE 192 Netherlands molecular diagnostics market estimates and forecasts, by infectious diseases, 2014 - 2026 (USD Million)
  • TABLE 193 Netherlands molecular diagnostics market estimates and forecasts, by genetic testing, 2014 - 2026 (USD Million)
  • TABLE 194 Poland molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 195 Poland molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 196 Poland molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 197 Poland PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 198 Poland PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 199 Poland ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 200 Poland INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 201 Poland chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 202 Poland mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 203 Poland sequencing market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 204 Poland TMA market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 205 Poland others technology market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 206 Poland molecular diagnostics market estimates and forecasts, by application, 2014 - 2026 (USD Million)
  • TABLE 207 Poland molecular diagnostics market estimates and forecasts, by oncology, 2014 - 2026 (USD Million)
  • TABLE 208 Poland molecular diagnostics market estimates and forecasts, by infectious diseases, 2014 - 2026 (USD Million)
  • TABLE 209 Poland molecular diagnostics market estimates and forecasts, by genetic testing, 2014 - 2026 (USD Million)
  • TABLE 210 Austria molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 211 Austria molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 212 Austria molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 213 Austria PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 214 Austria PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 215 Austria ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 216 Austria INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 217 Austria chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 218 Austria mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 219 Austria sequencing market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 220 Austria TMA market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 221 Austria others technology market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 222 Austria molecular diagnostics market estimates and forecasts, by application, 2014 - 2026 (USD Million)
  • TABLE 223 Austria molecular diagnostics market estimates and forecasts, by oncology, 2014 - 2026 (USD Million)
  • TABLE 224 Austria molecular diagnostics market estimates and forecasts, by infectious diseases, 2014 - 2026 (USD Million)
  • TABLE 225 Austria molecular diagnostics market estimates and forecasts, by genetic testing, 2014 - 2026 (USD Million)
  • TABLE 226 Greece molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 227 Greece molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 228 Greece molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 229 Greece PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 230 Greece PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 231 Greece ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 232 Greece INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 233 Greece chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 234 Greece mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 235 Greece sequencing market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 236 Greece TMA market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 237 Greece others technology market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 238 Greece molecular diagnostics market estimates and forecasts, by application, 2014 - 2026 (USD Million)
  • TABLE 239 Greece molecular diagnostics market estimates and forecasts, by oncology, 2014 - 2026 (USD Million)
  • TABLE 240 Greece molecular diagnostics market estimates and forecasts, by infectious diseases, 2014 - 2026 (USD Million)
  • TABLE 241 Greece molecular diagnostics market estimates and forecasts, by genetic testing, 2014 - 2026 (USD Million)
  • TABLE 242 Sweden molecular diagnostics market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 243 Sweden molecular diagnostics market estimates and forecasts, by test location, 2014 - 2026 (USD Million)
  • TABLE 244 Sweden molecular diagnostics market estimates and forecasts, by technology, 2014 - 2026 (USD Million)
  • TABLE 245 Sweden PCR market estimates and forecasts, by type, 2014 - 2026 (USD Million)
  • TABLE 246 Sweden PCR market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 247 Sweden ISH market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 248 Sweden INAAT market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 249 Sweden chips and microarrays market estimates and forecasts, by product, 2014 - 2026 (USD Million)
  • TABLE 250 Sweden mass spectrometry market estimates and forecasts, by product, 2014 - 2026 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Market summary, 2018
  • FIG. 4 Market trends & outlook
  • FIG. 5 Market segmentation & scope
  • FIG. 6 Market driver relevance analysis (Current & future impact)
  • FIG. 7 Global percentage of population, by age group, 2050 and 2000
  • FIG. 8 General trend shift from laboratory to Point of Care
  • FIG. 9 Market restrain relevance analysis (Current & future impact)
  • FIG. 10 Average selling price range of diagnostic tests, 2018
  • FIG. 11 Penetration & growth prospect mapping
  • FIG. 12 SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Molecular diagnostics market product outlook key takeaways
  • FIG. 15 Molecular diagnostics market: Product movement analysis
  • FIG. 16 Global instruments market, 2014 - 2026 (USD Million)
  • FIG. 17 Global reagents market, 2014 - 2026 (USD Million)
  • FIG. 18 Global others market, 2014 - 2026 (USD Million)
  • FIG. 19 Molecular diagnostics market test location outlook: Key takeaways
  • FIG. 20 Molecular diagnostics market: Test location movement analysis
  • FIG. 21 Global PoC market, 2014 - 2026 (USD Million)
  • FIG. 22 Global self-test or OTC market, 2014 - 2026 (USD Million)
  • FIG. 23 Global central laboratories market, 2014 - 2026 (USD Million)
  • FIG. 24 Molecular diagnostics market technology outlook: Key takeaways
  • FIG. 25 Molecular diagnostics market: Technology movement analysis
  • FIG. 26 Global PCR market, 2014 - 2026 (USD Million)
  • FIG. 27 Global multiplex PCR market, 2014 - 2026 (USD Million)
  • FIG. 28 Global other PCR market, 2014 - 2026 (USD Million)
  • FIG. 29 Global in situ hybridization market, 2014 - 2026 (USD Million)
  • FIG. 30 Global INAAT market, 2014 - 2026 (USD Million)
  • FIG. 31 Global chips and microarrays market, 2014 - 2026 (USD Million)
  • FIG. 32 Global mass spectrometry market, 2014 - 2026 (USD Million)
  • FIG. 33 Global sequencing market, 2014 - 2026 (USD Million)
  • FIG. 34 Global TMA market, 2014 - 2026 (USD Million)
  • FIG. 35 Global other market, 2014 - 2026 (USD Million)
  • FIG. 36 Molecular diagnostics market application outlook: Key takeaways
  • FIG. 37 Molecular diagnostics market: Application movement analysis
  • FIG. 38 Global oncology market, 2014 - 2026 (USD Million)
  • FIG. 39 Global breast cancer market, 2014 - 2026 (USD Million)
  • FIG. 40 Global prostate cancer market, 2014 - 2026 (USD Million)
  • FIG. 41 Global colorectal cancer market, 2014 - 2026 (USD Million)
  • FIG. 42 Global cervical cancer market, 2014 - 2026 (USD Million)
  • FIG. 43 Global kidney cancer market, 2014 - 2026 (USD Million)
  • FIG. 44 Global Liver Cancer market, 2014 - 2026 (USD Million)
  • FIG. 45 Global blood cancer market, 2014 - 2026 (USD Million)
  • FIG. 46 Global lung cancer market, 2014 - 2026 (USD Million)
  • FIG. 47 Global other market, 2014 - 2026(USD Million)
  • FIG. 48 Global pharmacogenomics market, 2014 - 2026(USD Million)
  • FIG. 49 Global infectious disease market, 2014 - 2026(USD Million)
  • FIG. 50 Global MRSA market, 2014 - 2026(USD Million)
  • FIG. 51 Global clostridium difficile market, 2014 - 2026(USD Million)
  • FIG. 52 Global vancomycin-resistant enterococci market, 2014 - 2026(USD Million)
  • FIG. 53 Global carbapenem-resistant bacteria market, 2014 - 2026(USD Million)
  • FIG. 54 Global flu market, 2014 - 2026 (USD Million)
  • FIG. 55 Global RSV market, 2014 - 2026(USD Million)
  • FIG. 56 Global candida market, 2014 - 2026(USD Million)
  • FIG. 57 Global tuberculosis and drug-resistant TB market, 2014 - 2026 (USD Million)
  • FIG. 58 Global meningitis market, 2014 - 2026 (USD Million)
  • FIG. 59 Global gastro-intestinal panel market, 2014 - 2026 (USD Million)
  • FIG. 60 Global chlamydia market, 2014 - 2026 (USD Million)
  • FIG. 61 Global gonorrhea market, 2014 - 2026 (USD Million)
  • FIG. 62 Global HIV market, 2014 - 2026(USD Million)
  • FIG. 63 Global hepatitis C market, 2014 - 2026 (USD Million)
  • FIG. 64 Global Hepatitis B market, 2014 - 2026(USD Million)
  • FIG. 65 Global market for others, 2014 - 2026 (USD Million)
  • FIG. 66 Global genetic testing market, 2014 - 2026(USD Million)
  • FIG. 67 Global newborn screening market, 2014 - 2026(USD Million)
  • FIG. 68 Global predictive and presymptomatic testing market, 2014 - 2026(USD Million)
  • FIG. 69 Global other market, 2014 - 2026 (USD Million)
  • FIG. 70 Global neurological disease market, 2014 - 2026(USD Million)
  • FIG. 71 Global cardiovascular disease market, 2014 - 2026(USD Million)
  • FIG. 72 Global microbiology market, 2014 - 2026(USD Million)
  • FIG. 73 Global other technology market, 2014 - 2026(USD Million)
  • FIG. 74 Regional market place: Key takeaways, 2018
  • FIG. 75 Regional outlook, 2018 & 2026
  • FIG. 76 North America molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 77 U.S. molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 78 Canada molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 79 Europe molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 80 U.K. molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 81 Germany molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 82 France molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 83 Spain molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 84 Italy molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 85 Belgium molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 86 Switzerland molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 87 Netherlands molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 88 Poland molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 89 Austria molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 90 Greece molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 91 Sweden molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 92 Turkey molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 93 Finland molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 94 Asia Pacific molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 95 Japan molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 96 China molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 97 India molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 98 Australia molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 99 New Zealand molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 100 Sri Lanka molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 101 Malaysia molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 102 Thailand molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 103 Vietnam molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 104 Singapore molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 105 Latin America molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 106 Brazil molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 107 Mexico molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 108 Colombia molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 109 Chile molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 110 Peru molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 111 Argentina molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 112 MEA molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 113 South Africa molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 114 Saudi Arabia molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 115 Jordan molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 116 UAE molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 117 Qatar molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 118 Nigeria molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 119 Egypt molecular diagnostics market, 2014 - 2026 (USD Million)
  • FIG. 120 Strategy framework
  • FIG. 121 Participant categorization
  • FIG. 122 North America molecular diagnostics market, 2014 - 2026 (USD Million)
Back to Top